BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35471455)

  • 1. Factors predicting recurrence in thymic epithelial neoplasms.
    Alkaaki A; Abo Al-Saud A; Di Lena É; Ramirez-GarciaLuna JL; Najmeh S; Spicer J; Ferri L; Mulder D; Sirois C; Cools-Lartigue J
    Eur J Cardiothorac Surg; 2022 Oct; 62(5):. PubMed ID: 35471455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database.
    Ruffini E; Detterbeck F; Van Raemdonck D; Rocco G; Thomas P; Weder W; Brunelli A; Evangelista A; Venuta F;
    Eur J Cardiothorac Surg; 2014 Sep; 46(3):361-8. PubMed ID: 24482389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behind and Beyond the Masaoka Staging: A 25-Year Follow-up Study of Tumor Recurrence in Completely Resected Thymic Epithelial Tumors in a Single Institution.
    Tseng YL; Chang JM; Lai WW; Chang KC; Lee SC; Lin SH; Yen YT
    Medicine (Baltimore); 2015 Dec; 94(52):e2278. PubMed ID: 26717364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of outcomes between neuroendocrine thymic tumours and other subtypes of thymic carcinomas: a joint analysis of the European Society of Thoracic Surgeons and the International Thymic Malignancy Interest Group.
    Filosso PL; Yao X; Ruffini E; Ahmad U; Antonicelli A; Huang J; Guerrera F; Venuta F; van Raemdonck D; Travis W; Lucchi M; Rimner A; Thomas P; Weder W; Rocco G; Detterbeck F; Korst R
    Eur J Cardiothorac Surg; 2016 Oct; 50(4):766-771. PubMed ID: 27032473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome and prognostic factors of surgically treated thymic carcinoma: results of 306 cases from a Japanese Nationwide Database Study.
    Hishida T; Nomura S; Yano M; Asamura H; Yamashita M; Ohde Y; Kondo K; Date H; Okumura M; Nagai K;
    Eur J Cardiothorac Surg; 2016 Mar; 49(3):835-41. PubMed ID: 26116920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of surgical treatment of Masaoka stage III-IV thymic epithelial tumors.
    Hamanaka K; Koyama T; Matsuoka S; Takeda T; Miura K; Yamada K; Hyogotani A; Seto T; Okada K; Ito KI
    Gen Thorac Cardiovasc Surg; 2018 Dec; 66(12):731-735. PubMed ID: 30132223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of a new tumour-node-metastasis staging system for thymic malignancies proposed by the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee and the International Thymic Malignancy Interest Group.
    Fukui T; Fukumoto K; Okasaka T; Kawaguchi K; Nakamura S; Hakiri S; Ozeki N; Hirakawa A; Tateyama H; Yokoi K
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):574-9. PubMed ID: 26547095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical resection of Masaoka stage III thymic epithelial tumours with great vessels involvement: a retrospective multicentric analysis from the European Society of Thoracic Surgeons thymic database.
    Mendogni P; Toker A; Moser B; Trancho FH; Aigner C; Bravio IG; Novoa NM; Molins L; Costardi L; Voltolini L; Ardò NP; Verdonck B; Ampollini L; Zisis C; Barmin V; Enyedi A; Ruffini E; Van Raemdonck D; Thomas PA; Weder W; Rocco G; Brunelli A; Detterbeck FC; Venuta F; Falcoz PE; Tosi D; Bonitta G; Nosotti M;
    Eur J Cardiothorac Surg; 2022 Sep; 62(4):. PubMed ID: 35084028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node metastases in thymic malignancies: a Chinese Alliance for Research in Thymomas retrospective database analysis.
    Gu Z; Wei Y; Fu J; Tan L; Zhang P; Han Y; Chen C; Zhang R; Li Y; Chen K; Chen H; Liu Y; Cui Y; Wang Y; Pang L; Yu Z; Zhou X; Liu Y; Shen Y; Fang W;
    Interact Cardiovasc Thorac Surg; 2017 Sep; 25(3):455-461. PubMed ID: 28521033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of tumour size in completely resected thymic epithelial tumours.
    Fukui T; Fukumoto K; Okasaka T; Kawaguchi K; Nakamura S; Hakiri S; Ozeki N; Hirakawa A; Tateyama H; Yokoi K
    Eur J Cardiothorac Surg; 2016 Dec; 50(6):1068-1074. PubMed ID: 27999073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological features of thymic carcinomas and the impact of histopathological agreement on prognostical studies.
    Roden AC; Yi ES; Cassivi SD; Jenkins SM; Garces YI; Aubry MC
    Eur J Cardiothorac Surg; 2013 Jun; 43(6):1131-9. PubMed ID: 23086701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors: the Japanese Association for Research on the Thymus Database Study.
    Omasa M; Date H; Sozu T; Sato T; Nagai K; Yokoi K; Okamoto T; Ikeda N; Tanaka F; Maniwa Y;
    Cancer; 2015 Apr; 121(7):1008-16. PubMed ID: 25565590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG PET-CT aids in the preoperative assessment of patients with newly diagnosed thymic epithelial malignancies.
    Benveniste MF; Moran CA; Mawlawi O; Fox PS; Swisher SG; Munden RF; Marom EM
    J Thorac Oncol; 2013 Apr; 8(4):502-10. PubMed ID: 23446204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes after surgical resection of thymic carcinoma: A study from a single tertiary referral centre.
    Song Z; Zhang Y
    Eur J Surg Oncol; 2014 Nov; 40(11):1523-7. PubMed ID: 24953416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ¹⁸F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival.
    Seki N; Sakamoto S; Karube Y; Oyaizu T; Ishihama H; Chida M
    Ann Nucl Med; 2014 Apr; 28(3):257-62. PubMed ID: 24430867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors of patients with thymic carcinoma after surgery: a retrospective analysis of 58 cases.
    Wang S; Wang Z; Liu X; Wang D; Liu F
    World J Surg; 2014 Aug; 38(8):2032-8. PubMed ID: 24615610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors of stage I thymic epithelial tumors.
    Fukui T; Kadomatsu Y; Tsubouchi H; Nakanishi K; Ueno H; Sugiyama T; Goto M; Ozeki N; Nakamura S; Chen-Yoshikawa TF
    Gen Thorac Cardiovasc Surg; 2021 Jan; 69(1):59-66. PubMed ID: 32621280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant thymomas--the experience of the Portuguese Oncological Institute, Porto, and literature review.
    Sousa B; Araújo A; Amaro T; Azevedo I; Soares M; Sousa O
    Rev Port Pneumol; 2007; 13(4):553-85. PubMed ID: 17898913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended surgical resections of advanced thymoma Masaoka stages III and IVa facilitate outcome.
    Ried M; Potzger T; Sziklavari Z; Diez C; Neu R; Schalke B; Hofmann HS
    Thorac Cardiovasc Surg; 2014 Mar; 62(2):161-8. PubMed ID: 23775415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical treatment of stage III thymic tumors: a multi-institutional review from four Italian centers.
    Marulli G; Lucchi M; Margaritora S; Cardillo G; Mussi A; Cusumano G; Carleo F; Rea F
    Eur J Cardiothorac Surg; 2011 Mar; 39(3):e1-7. PubMed ID: 21193321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.